Published in
Springer (part of Springer Nature), Breast Cancer Research and Treatment, 3(151), p. 597-606
DOI: 10.1007/s10549-015-3415-2
Links
Tools
Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study
Journal article published in 2015 by
Miguel J. Gil-Gil,
M. Bellet,
S. Morales 
,
B. Ojeda,
L. Manso,
C. Mesia,
E. Garcia-Martínez,
N. Martinez-Jáñez,
M. Melé ,
A. Llombart,
S. Pernas,
P. Villagrasa,
C. Blasco,
J. Baselga
,
B. Ojeda,
L. Manso,
C. Mesia,
E. Garcia-Martínez,
N. Martinez-Jáñez,
M. Melé ,
A. Llombart,
S. Pernas,
P. Villagrasa,
C. Blasco,
J. Baselga
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 